KOSDAQ · Healthcare · ₩56B
₩5,030+9.59%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 4.6% · as of 26.10.27
Among 34 바이오 peers
Quarterly Revenue Growth
“생산 서비스 매출은 확인됐고 신약 진척이 다음 열쇠예요.”
In the company's words · 2026 2분기 filing